Arcadia Biosciences, Inc. (RKDA) Q4 2024 Results Conference Call:
On March 20, 2025, at 4:30 PM ET, Arcadia Biosciences, Inc. (RKDA) held its Fourth Quarter and Full Year 2024 Financial Results and Business Highlights Conference Call. The participants from Arcadia Biosciences included Mark Kawakami, Chief Financial Officer, and T.J. Schaefer, President & Chief Executive Officer. Ben Klieve from Lake Street Capital Markets served as the conference call operator.
Company Participants:
- Mark Kawakami – Chief Financial Officer
- T.J. Schaefer – President & Chief Executive Officer
Conference Call Participants:
- Ben Klieve – Lake Street Capital Markets
During the call, T.J. Schaefer began by expressing his gratitude to investors for their continued support. He then highlighted the company’s accomplishments in 2024, which included the launch of its GoodHerenity Soybean Trait in the US and Canada, the expansion of its partnership with Bayer AG, and the acquisition of a leading food ingredient company.
Mark Kawakami then provided a detailed financial overview, reporting a net loss of $12.5 million for the quarter, compared to a net loss of $9.5 million in the same period the previous year. He also reported a full-year net loss of $35.7 million, compared to a net loss of $31.2 million in 2023. Revenues for the quarter came in at $11.5 million, up from $10.2 million in Q4 2023.
Schaefer went on to discuss the company’s strategic initiatives for 2025, including the expansion of its GoodHerenity Soybean Trait into new markets, the launch of new products in its NutriCoco line, and the continued development of its GoodWheat trait. He also highlighted the company’s commitment to sustainability and reducing the carbon footprint of agriculture.
Impact on Individuals:
The results and highlights from Arcadia Biosciences’ Q4 2024 conference call may not have a direct impact on individuals, but the company’s work in developing sustainable agricultural solutions could lead to more affordable and nutritious food options in the future. The launch of new products, such as those in the NutriCoco line, could also provide consumers with healthier alternatives to traditional ingredients.
Impact on the World:
The work of Arcadia Biosciences could have a significant impact on the world by addressing food security and sustainability challenges. The company’s GoodHerenity Soybean Trait, which is resistant to Roundup herbicides, could help farmers reduce their use of chemicals and improve crop yields. Additionally, the company’s GoodWheat trait, which is designed to reduce the amount of gluten in wheat, could benefit individuals with celiac disease and non-celiac gluten sensitivity. The company’s commitment to sustainability could also help reduce the carbon footprint of agriculture and contribute to a more sustainable food system.
Conclusion:
During its Q4 2024 conference call, Arcadia Biosciences reported a net loss for the quarter and the full year, but also highlighted its accomplishments in 2024 and its strategic initiatives for 2025. The company’s work in developing sustainable agricultural solutions could have a significant impact on food security and sustainability, as well as provide consumers with healthier food options. While the results of the conference call may not have a direct impact on individuals, the potential benefits of the company’s work could be felt globally.
